MRPL42 is activated by YY1 to promote lung adenocarcinoma progression.

Jiang, Wei; Zhang, Chengpeng; Kang, Yunteng; Yu, Xiaojun; Pang, Pei; Li, Guangbin; Feng, Yu

Jiang, Wei; Zhang, Chengpeng; Kang, Yunteng; Yu, Xiaojun; Pang, Pei; Li, Guangbin; Feng, Yu.

Afiliação

Jiang W; Department of Thoracic Surgery, the First Affiliated Hospital of Soochow, University, Suzhou, Jiangsu, China.
Zhang C; Department of Thoracic Surgery, the First Affiliated Hospital of Soochow, University, Suzhou, Jiangsu, China.
Kang Y; Department of Thoracic Surgery, the First Affiliated Hospital of Soochow, University, Suzhou, Jiangsu, China.
Yu X; Department of Thoracic Surgery, the First Affiliated Hospital of Soochow, University, Suzhou, Jiangsu, China.
Pang P; Department of Pathology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Li G; Department of Thoracic Surgery, the First Affiliated Hospital of Soochow, University, Suzhou, Jiangsu, China.
Feng Y; Department of Thoracic Surgery, the First Affiliated Hospital of Soochow, University, Suzhou, Jiangsu, China.

J Cancer ; 12(8): 2403-2411, 2021.

Article em En | MEDLINE | ID: mdl-33758616

Palavras-chave

MRPL42; YY1; metastasis; proliferation; transcriptional regulation

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Austrália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google